Comprehensive Summary: Effect of Dietary Patterns on Long-Term Weight Maintenance of Patients After Sleeve Gastrectomy
Published on: 12 Sept 2025
Introduction and Background
Obesity, characterized by excessive adipose tissue accumulation, has become a critical global public health challenge, affecting over 1.9 billion overweight and approximately 650 million obese adults worldwide. Projections estimate that adult obesity prevalence could reach 42% by 2030. Obesity significantly increases the risk of comorbidities such as cardiovascular disease, type 2 diabetes mellitus (T2DM), malignancies, obstructive sleep apnea, fatty liver disease, and gallbladder disorders.
When conservative treatments fail, bariatric surgery offers the most effective strategy for weight loss and metabolic improvement. Among bariatric procedures, Sleeve Gastrectomy (SG) and Roux-en-Y Gastric Bypass (RYGB) are the most commonly performed. SG, which involves creating a sleeve-like gastric pouch connecting the esophagus to the small intestine, is increasingly preferred due to shorter operative time and comparable weight loss outcomes. SG induces weight loss by reducing gastric volume, altering nutrient intake, digestion, absorption, and modulating gut hormone secretion, including GLP-1, PYY, and oxyntomodulin, that regulate appetite and glucose homeostasis.
Physiological and Metabolic Effects of Sleeve Gastrectomy
SG induces significant changes in dietary habits, food tolerance, and preferences. Carbohydrates like noodles and certain meats (chicken, turkey, fish) are generally well-tolerated, while full-fat milk and carbonated beverages are poorly tolerated, though food intolerance is often temporary and improves over time. Post-SG, patients tend to reduce consumption of sweets, fats, alcohol, and salty foods, showing increased preference for tart flavors in some studies, though results vary.
Anatomical changes post-SG reduce gastric acid and intrinsic factor secretion, impairing digestion and absorption, especially of fat-soluble vitamins (A, D, E, K). Accelerated gastric emptying leads to rapid nutrient transit to the small intestine and altered digestion rates. Furthermore, SG elevates gut hormones such as GLP-1 and PYY, enhancing satiety and improving glucose metabolism. It also reduces oxidative stress markers and pro-inflammatory cytokines, indicating improved metabolic health and systemic inflammation reduction postoperatively.
Nutritional Challenges: Malnutrition and Weight Regain (WR)
Despite consuming excessive calories preoperatively, patients with obesity often suffer from nutritional deficiencies due to poor diet quality. Post-SG, malnutrition remains a significant concern, with common deficiencies in vitamins and micronutrients leading to anemia, metabolic bone diseases (osteoporosis, fractures), and neurological complications (Wernicke’s encephalopathy, optic neuropathy).
Contributing factors to malnutrition include reduced dietary intake, altered food preferences, postoperative symptoms (vomiting, nausea), and poor adherence to supplementation guidelines, with adherence rates below 20%. These challenges underscore the need for affordable and sustainable dietary management strategies in SG patients.
Weight regain (WR) after SG is increasingly recognized, with reported rates ranging from 15.4% to 50%. WR is strongly associated with unhealthy dietary behaviors such as frequent consumption of sweetened beverages, high carbohydrate/low protein intake, poor adherence to dietary guidelines, and maladaptive eating patterns including grazing and binge eating. Additional risk factors include higher preoperative BMI, sex differences (males at higher risk), and age, although findings on age are inconsistent.
Mechanistically, WR involves complex hormonal changes, such as the normalization of ghrelin levels over time, which may increase energy intake. Adipose tissue dynamics, including impaired extracellular matrix remodeling and persistent fatty acid uptake by adipocytes despite fat mass reduction, promote fat re-accumulation. Immune-metabolic memory characterized by persistent inflammation and innate immune activation also contributes to WR.
Therapeutic Strategies for Weight Regain
Current interventions for WR include dietary modifications, behavioral therapy, pharmacotherapy, and revisional surgery. Behavioral and lifestyle interventions show partial success in preventing WR, but pharmacological treatments post-SG appear less effective compared to other bariatric procedures. Revisional surgery, mainly conversion to RYGB, is used in some cases but carries higher risks. Emerging endoscopic approaches offer less invasive alternatives. Overall, there is a pressing need for robust randomized controlled trials (RCTs) to develop integrated and personalized treatment strategies.
Dietary Patterns and Their Impact on Weight Maintenance Post-SG
Long-term success after SG heavily depends on tailored dietary management to prevent WR and malnutrition. Early postoperative care (6–12 months) focuses on adequate protein and fluid intake to preserve muscle mass, while long-term management (>1 year) emphasizes controlled energy intake and nutrient supplementation.
Several dietary patterns have shown promise:
-
High-Protein Diet:
Current guidelines recommend ≥35% energy from protein, 60–80 g/day or 1.2–1.5 g/kg of ideal body weight, to preserve lean body mass and basal metabolic rate. High protein promotes satiety, stimulates anorexigenic hormones, increases thermogenesis, and enhances fat oxidation. Studies indicate that higher protein intake correlates with greater long-term weight loss and reduced fat-free mass loss post-SG. -
Mediterranean Diet (MedDiet):
Rich in plant-based foods, olive oil, nuts, moderate animal products, and low in saturated fats, MedDiet improves lipid profiles, reduces inflammation, modulates molecular pathways (mTOR), and promotes beneficial gut microbiota metabolites. Its high fiber content enhances satiety by stimulating GLP-1 and PYY secretion, counteracting accelerated gastric emptying post-SG. Adherence to MedDiet correlates with reduced WR and improved metabolic health over long-term follow-up. -
Low-Carbohydrate (LC) and Very Low-Calorie Ketogenic Diets (VLCKD):
LC diets limit carbohydrate intake to <130 g/day, promoting fat metabolism. VLCKD, with 500–800 kcal/day and <50 g carbohydrates, induces ketosis, which helps regulate appetite. Studies report significant weight loss and muscle strength preservation with VLCKD, suggesting potential benefits for “poor responders” post-bariatric surgery. Adequate protein intake in these diets supports gluconeogenesis and prevents muscle loss, a critical factor in avoiding WR.
Conclusions and Clinical Implications
SG effectively induces weight loss and metabolic improvements through anatomical, hormonal, and physiological changes. However, postoperative malnutrition and WR remain persistent challenges, largely due to poor adherence to supplementation and dietary recommendations.
Emerging evidence supports the implementation of high-protein, Mediterranean, and low-carbohydrate dietary patterns to sustain weight loss and reduce WR risk after SG. Nonetheless, further prospective studies are necessary to elucidate their long-term efficacy and mechanisms, as well as to identify patient subgroups that may benefit most from specific dietary strategies.
Clinicians are encouraged to assess preoperative nutritional status, individual eating habits, preferences, and lifestyle factors to tailor nutritional plans. Proactive nutritional supplementation, vigilant postoperative monitoring, and regular follow-up are essential to optimize patient outcomes and mitigate public health burdens related to obesity and bariatric surgery.
SOURCE/READ THE FULL ARTICLE: https://pubmed.ncbi.nlm.nih.gov/40951579/
LEARN MORE ABOUT THE MUSLIM WEIGHT MANAGEMENT
